Semaglutide Reduces CV Events in High-Risk Patients with Type 2 Diabetes Mellitus

Mark H. Ebell

Research output: Contribution to journalArticle

Original languageEnglish (US)
Number of pages1
JournalAmerican family physician
Volume95
Issue number6
StatePublished - Mar 15 2017

Fingerprint

Type 2 Diabetes Mellitus
semaglutide

ASJC Scopus subject areas

  • Family Practice

Cite this

Semaglutide Reduces CV Events in High-Risk Patients with Type 2 Diabetes Mellitus. / Ebell, Mark H.

In: American family physician, Vol. 95, No. 6, 15.03.2017.

Research output: Contribution to journalArticle

@article{e43505c2018a4e0ca1202c5ce8239c3d,
title = "Semaglutide Reduces CV Events in High-Risk Patients with Type 2 Diabetes Mellitus",
author = "Ebell, {Mark H.}",
year = "2017",
month = "3",
day = "15",
language = "English (US)",
volume = "95",
journal = "American Family Physician",
issn = "0002-838X",
publisher = "American Academy of Family Physicians",
number = "6",

}

TY - JOUR

T1 - Semaglutide Reduces CV Events in High-Risk Patients with Type 2 Diabetes Mellitus

AU - Ebell, Mark H.

PY - 2017/3/15

Y1 - 2017/3/15

UR - http://www.scopus.com/inward/record.url?scp=85056257283&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85056257283&partnerID=8YFLogxK

M3 - Article

VL - 95

JO - American Family Physician

JF - American Family Physician

SN - 0002-838X

IS - 6

ER -